S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

OLMA Olema Pharmaceuticals Inc

5.20

0.36 (7.44%)

Pre Market

Last Updated: 00:59:52

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Olema Pharmaceuticals (NASDAQ:OLMA)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Olema Pharmaceuticals Charts.

Olema Pharmaceuticals (NASDAQ:OLMA)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Olema Pharmaceuticals Charts.

Olema Pharmaceuticals Inc News

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Tuesday 14 January 2025 (17 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 13 January 2025 (1 day ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 11 January 2025 (4 days ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Tuesday 7 January 2025 (1 week ago) • Edgar (US Regulatory)

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Saturday 4 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare Conference
Thursday 2 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 14 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 12 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 12 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 12 December 2024 (1 month ago) • Edgar (US Regulatory)

More Olema Pharmaceuticals Inc News Articles

Amundi MSCI China ESG Le...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions